By the end of 2009, the total assets of Tianjin Pharmaceutical Group were 21400 million yuan, and it owned two listed companies, Tianjin Zhongxin Pharmaceutical Group Co., Ltd. and Tianjin Li Sheng Pharmaceutical Co., Ltd., and a national pharmaceutical research institute, Tianjin Pharmaceutical Research Institute. The pharmaceutical industry is the main part of the group, and scientific research, production and commercial sales support each other, forming a relatively complete industrial pattern in which chemical drugs, modern Chinese medicine, medical devices and pharmaceutical business rely on each other. The Group has 93 holding or shareholding enterprises, including 65,438+03 joint ventures with world-renowned enterprises such as GlaxoSmithKline, Takeda, Otsuka, Baxter and Ipsen. In 2009, the Group achieved a total industrial output value of 6.77 billion yuan, industrial and commercial sales income of 65.438+0.573 billion yuan and profit of 65.438+0.465438+0.5 billion yuan.
After years of reform and development, Tianjin Pharmaceutical Group has formed an advantageous enterprise group with development potential. In the production of chemical drugs, a number of key enterprises for the production of chemical raw materials and preparations have been formed, such as Li Sheng Pharmaceutical Company, Central Pharmaceutical Company, Jin Kang Pharmaceutical Company, Sino-American SmithKline Pharmaceutical Company and China Otsuka Pharmaceutical Company. In the traditional Chinese medicine industry, with rich variety resources of Chinese patent medicines, unique advantages of industrial and commercial integration and strong financial support, Zhongxin Pharmaceutical, Liu Traditional Chinese Medicine, Darentang, Lerentang, Long Shunrong, Tongrentang and Hongrentang have become well-known brands at home and abroad. In the field of biopharmaceuticals, Hualida Bioengineering Technology Co., Ltd. is in the leading position of genetic engineering pharmaceutical technology in China. At present, the group is producing more than 900 kinds of products. Among them, Fenbid, Xiao Su Jiuxin Pill, Shoubishan, etc. 15 varieties, Shoubishan, Darentang, Jingwanhong, etc. 3 well-known trademarks in China, Hongrentang, etc. 5 Chinese time-honored brands, and Shifuni, etc. 19 famous trademarks in Tianjin.
Tianjin Pharmaceutical Group will unswervingly adhere to the development concept of "serving human health", aim at the international advanced level, continuously improve the ability of scientific and technological innovation, speed up the upgrading of product quality, contribute more to the cause of human health with excellent products and services, and create higher value for society.